Outcome of distal gastric cancer with pyloric stenosis after curative resection

European Journal of Surgical Oncology

Volumn 33, Issue 5, 2007, Pages 556-560

  Chen, J H ^a   Wu, C W ^a   Lo, S S ^a   Li, A F Y ^a   Hsieh, M C ^a   Shen, K H ^a   Lui, W Y ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Curative resection; Distal third gastric cancer; Pyloric stenosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GASTRECTOMY; GENERAL HOSPITAL; HUMAN; LAPAROTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PYLORUS STENOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; SYMPTOM; TAIWAN; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; PROGNOSIS; PYLORIC STENOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 34248580522     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.01.020     Document Type: Article

References (14)

1. Crew K.D., and Neugut A.I. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31 (2004) 450-464
2. Wu C.W., Lo S.S., Shen K.H., et al. Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer. World J Surg 27 (2003) 153-158
3. Wu C.W., Hsieh M.C., Lo S.S., Tsay S.H., Lui W.Y., and P'eng F.K. Lymph node metastasis from carcinoma of the distal one-third of the stomach. Cancer 73 (1994) 2059-2064
4. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer 1 (1998) 10-24
5. Watanabe A., Maehara Y., Okuyama T., Kakeji Y., Korenaga D., and Sugimachi K. Gastric carcinoma with pyloric stenosis. Surgery 123 (1998) 330-334
6. Wu C.W., Hsieh M.C., Lo S.S., et al. Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach. Digest Dis Sci 42 (1997) 1265-1269
7. Maruyama K. The most important prognostic factors for gastric cancer patients. Scand J Gastroenterol 32 Suppl 2 (1987) 63-68
8. Maehara Y., Tomoda M., Tomisaki S., et al. Surgical treatment and outcome for node-negative gastric cancer. Surgery 121 (1997) 633-639
9. Adachi Y., Mori M., Maehara Y., Kitano S., and Sugimachi K. Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. J Am Coll Surg 184 (1997) 373-377
10. Bruno L., Nesi G., Montinaro F., et al. Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol 74 (2000) 30-32
11. Kooby D., Suriawinata A., Klimstra D.S., Brennan M.F., and Karpeh M.S. Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237 (2003) 828-837
12. Wu C.W., Hsieh M.C., Lo S.S., Lui W.Y., and P'eng F.K. Results of curative gastrectomy for carcinoma of the distal third stomach. J Am Coll Surg 183 (1996) 201-207
13. Kanai T., Konno H., Maruyama K., et al. p53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer. Eur Surg Res 29 (1997) 35-41
14. Wu C.W., Hsieh M.C., Lo S.S., Shen K.H., Lui W.Y., and P'eng F.K. Comparison of the UICC/AJCC 1992 and 1997 pN categories for gastric cancer patients after surgery. Hepato-Gastroenterology 48 (2001) 279-284